Anti-IgE therapy in asthma: rationale and therapeutic potential.
about
Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisonsCorticosteroids, IgE, and atopyOmalizumab: the evidence for its place in the treatment of allergic asthmaFrom IgE to anti-IgE: where do we stand?Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation.Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.
P2860
Anti-IgE therapy in asthma: rationale and therapeutic potential.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@ast
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@en
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@nl
type
label
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@ast
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@en
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@nl
prefLabel
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@ast
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@en
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@nl
P356
P1476
Anti-IgE therapy in asthma: rationale and therapeutic potential.
@en
P2093
P304
P356
10.1159/000024444
P577
2000-11-01T00:00:00Z